Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
José Mayordomo(Royal Bournemouth Hospital), M T Lotze(UPMC Hillman Cancer Center), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Tatiana Zorina(UPMC Hillman Cancer Center), W. Martin Kast(University of Southern California), Christina M. Celluzzi(UPMC Hillman Cancer Center), Laurence Zitvogel(Institut Gustave Roussy), Walter J. Storkus(University of Pittsburgh Medical Center), S T Ildstad(University of Louisville), Albert B. DeLeo(University of Pittsburgh), Louis D. Falo(University of Pittsburgh Medical Center)
Cited by 1,105
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Molecular Characterization of Dendritic Cell-Derived Exosomes
|The Journal of Cell Biology|1999|1.1k
CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner
|The Journal of Experimental Medicine|2005|918